Cargando…
Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine‐induced blood brain barrier dysfunction via suppression of MLCK signaling pathway
INTRODUCTION: Multiple sclerosis (MS) disease activity is associated with blood‐brain barrier (BBB) disruption, which is mediated by inflammatory cytokines released by CD4+ lymphocytes. To assess the effects of adenosine A2A receptors on BBB permeability in vitro and in vivo. METHODS: A2A receptor e...
Autores principales: | Liu, Ying, Alahiri, Marwan, Ulloa, Bianca, Xie, Boxun, Sadiq, Saud A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818446/ https://www.ncbi.nlm.nih.gov/pubmed/29027376 http://dx.doi.org/10.1002/iid3.187 |
Ejemplares similares
-
Monitoring MLCK
por: Wells, William A.
Publicado: (2002) -
Amelioration of IFN-γ and TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Berberine via Suppression of MLCK-MLC Phosphorylation Signaling Pathway
por: Cao, Min, et al.
Publicado: (2013) -
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis
por: Graham, W Vallen, et al.
Publicado: (2019) -
Oleanolic acid ameliorates intestinal alterations associated with EAE
por: Gutierrez, Beatriz, et al.
Publicado: (2020) -
AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation
por: Ye, Xiaolin, et al.
Publicado: (2017)